Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2003
11/26/2003CN1458281A Coronary virus RNA interference preparation for severe acute respiratory syndrome pathogen
11/26/2003CN1458280A Two artificial synthetic PRRS virus multiple opitope tandem pucleotide sequences and their use
11/26/2003CN1458167A Truncated express pig gyrate virus Ôàí type capsid protein antigen and its use
11/26/2003CN1457885A Rhinitis and nasosinusitis resisting specific IgY and its combined preparation
11/26/2003CN1457883A Alpha type recombined human interferon suppository and producing process
11/26/2003CN1457882A Recombined human interleukin-2 and its derivative injection and preparing method
11/26/2003CN1457879A Meningococcal vaccine and its preparing method
11/26/2003CN1457877A Aikang soft capsule fortreating AIDS and preparing method
11/26/2003CN1457876A New use of fleahane preparation for teating acute respiratory distress syndrome
11/26/2003CN1457871A Taiyi liver protection capsule and its preparing method
11/26/2003CN1457870A Medicine for treating pneumonia and SARS
11/26/2003CN1457864A Pill for treating pestilence, high fever and headache
11/26/2003CN1457862A Paste for treating cardio-cerebral vascular diseases, hepatitis and ruducing blood fat and blood pressure
11/26/2003CN1457854A Health pill for liver
11/26/2003CN1457851A Chinese medicine formula with treating and health function
11/26/2003CN1457839A Medicinal composition for preventing and curing SARS and its preparing method
11/26/2003CN1457838A Chines medicinal composition for curing hepatitis B
11/26/2003CN1457836A Pure Chinese medicinal preparation for quickly curing SARS
11/26/2003CN1457834A Detoxicating pill
11/26/2003CN1457830A Compound Chinese medicine preparation for curing asthma and assisted curing tumor and AIDS and its preparing method
11/26/2003CN1457817A New preparation of mulberry leaf and chrysanthemum common cold tablet and preparing process
11/26/2003CN1457814A Medicine for curing tinea pedis
11/26/2003CN1457801A Medicinal composition for curing common cold
11/26/2003CN1457798A Hydroypropyl-beta-cyclodextrin inclusion of Rhizoma Zedoariae oil and preparation and preparing method
11/26/2003CN1457797A Composition with anti-virus function and its preparing process
11/26/2003CN1457796A Ribavirin inhalation powder atomizing agent and its preparing process and anti-virus infection use
11/26/2003CN1457783A Sparxacin dripping pill for resisting bacterial infection and its preparing method
11/26/2003CN1457782A Dry spaxxacin suspension agent for resisting bacterial infection and its preparing method
11/26/2003CN1457778A Subprostrate sophora oral preparation, preparing method and use
11/26/2003CN1457777A New use of indole derivatives as anti-SARS medicine
11/26/2003CN1457776A Self emulsified soft capsule of ginkgo leaf extract and its preparing method
11/26/2003CN1457771A 1'-acetoxyl chavicol acetate with anti-HIV activity and its derivatives
11/26/2003CN1457770A Anti-virus arosol inhalation medicine liquid
11/26/2003CN1457766A Mucilage antiseptic medicine composition capable of being locally administratied and sustainably released and its preparing method
11/26/2003CN1128790C 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents
11/26/2003CN1128622C Medicinal composition for treating AIDS
11/26/2003CN1128618C Use of histamine for elevating blood histamine
11/26/2003CN1128615C Pharmaceutical compositions for prevention and treatment of cancerous disease and process for their preparation
11/25/2003US6653475 Coupling a compound with pyrimidone intermediate
11/25/2003US6653443 Viral infectivity factor protein (Vif) antagonist that binds to the multimerization domain within a Vif protein in a cell and inhibits Vif protein; treating acquired immunodeficiency syndrome (AIDS)
11/25/2003US6653347 For therapy
11/25/2003US6653330 Amide-type triazole compounds
11/25/2003US6653326 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof
11/25/2003US6653313 1,4-dihydropyridine compounds as bradykinin antagonists
11/25/2003US6653312 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
11/25/2003US6653310 For therapy of disease states mediated by the chemokine, Interleukin-8 (IL-8)
11/25/2003US6653307 1-aryl-4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents
11/25/2003US6653301 For therapy of cancer, diabetes and Alzheimer's disease
11/25/2003US6653300 Pyrazole compounds useful as protein kinase inhibitors
11/25/2003US6653299 Labelled factor XIIIa substrates
11/25/2003US6653296 Antiretroviral enantiomeric nucleotide analogs
11/25/2003US6653293 Administering substance stimulating infected cells to increase HIV replication; causing extracorporeal apoptosis and reinfusing blood
11/25/2003US6653292 Stimulating Th1 pattern of immune activation, cytokine production, NK lytic activity and B cell proliferation; modulating with nucleic acid sequences containing unmethylated CpG dinucleotides
11/25/2003US6653281 Ring modified cyclic peptide analogs
11/25/2003US6653125 Synthetic hepatitis C genes
11/25/2003US6653069 Method for quality control of an attenuated vericella live vaccine
11/25/2003US6652864 Administering compound of nerve growth factor-enzymatically cleavable amide linker-viricide
11/25/2003US6652862 Biologically active bactericidal/permeability-increasing protein fragments
11/25/2003US6652857 Methods for producing avian verotoxin antitoxin
11/25/2003US6652851 Cloning and recombinant production of polistinae venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon
11/25/2003CA2258811C Formulation for use in the prevention of pathogen induced diseases including hiv and hsv
11/25/2003CA2194166C Multi-stage cascase boosting vaccine
11/25/2003CA2134679C Soluble analogs of probucol
11/25/2003CA2106370C Antibiotic compounds
11/25/2003CA2086888C Whooping cough vaccine
11/25/2003CA2080820C Azo-derivatives, pharmaceutical preparations containing them, and their uses
11/20/2003WO2003096017A1 Methods and compositions for inducing an immune response
11/20/2003WO2003095971A2 Posh nucleic acids, polypeptides and related methods
11/20/2003WO2003095665A2 Pmea and pmpa cyclic producing synthesis
11/20/2003WO2003095634A1 Pax-5-deficient pro-b-cells, methods of producing them and the use of such cells in human therapy
11/20/2003WO2003095613A2 Nucleic acids, polypeptides, and methods for modulating apoptosis
11/20/2003WO2003095498A1 Complex of organic medicines and beta-cyclodextrin derivatives and its preparing process
11/20/2003WO2003095493A2 Toxin-related antibodies with antimicrobial and antiviral activity
11/20/2003WO2003095487A2 Immunogenic cd1 complexes
11/20/2003WO2003095482A2 Novel cyclic peptides and use thereof as anti-microbial agents
11/20/2003WO2003095455A2 Substituted pyrazolopyrimidines
11/20/2003WO2003095454A1 1ß-METHYLCARBAPENEM DERIVATIVE FOR ORAL ADMINISTRATION
11/20/2003WO2003095453A1 Compounds against helicobacter activity
11/20/2003WO2003095452A1 Substituted pyrroline kinase inhibitors
11/20/2003WO2003095447A1 Process for the preparation of a hydrate of an anthranilic acid derivative
11/20/2003WO2003095441A1 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
11/20/2003WO2003095435A1 Amide derivatives
11/20/2003WO2003095433A1 Hexahydro-pyridazine-3-carboxylic acid derivatives, pharmaceutical compositions containing same and preparation methods thereof
11/20/2003WO2003095398A2 Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same
11/20/2003WO2003094963A2 Methylated immunostimulatory oligonucleotides and methods of using the same
11/20/2003WO2003094960A2 Mucosal combination vaccines for bacterial meningitis
11/20/2003WO2003094946A1 Hepatoprotective activity of 2'-p-hydroxybenzoylmussaenosidic acid
11/20/2003WO2003094942A1 Soluble composition containing sporopollenin and the use thereof
11/20/2003WO2003094920A1 Microbicidal pyrimidine or triazine for preventing sexual hiv transmission
11/20/2003WO2003094919A2 Novel crystalline forms of gatifloxacin
11/20/2003WO2003094911A1 Hepatoprotective activity of 10-o-p-hydroxybenzoyiaucubin
11/20/2003WO2003094906A1 Anti-rhinovirus active agents
11/20/2003WO2003094902A2 Surface treatment of sars-infected lungs
11/20/2003WO2003094894A1 Nanoparticulate nystatin formulations
11/20/2003WO2003094890A1 Capsules for dry powder inhalers and methods of making and using same
11/20/2003WO2003094878A1 Gallocatechin gallate-containing composition
11/20/2003WO2003094850A2 Lipid a and other carbohydrate ligand analogs
11/20/2003WO2003094836A2 Methods and products for enhancing immune responses using imidazoquinoline compounds
11/20/2003WO2003094834A2 Mucosal vaccines with chitosan adjuvant and meningococcal antigens
11/20/2003WO2003094829A2 Pathogen vaccines and methods for using the same
1 ... 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 ... 1798